Learn more →
Back to Expert Scholars
clinical / clinicalradiation biology

Peter Hoskin

彼得·霍斯金

MD, FRCR

🏢Mount Vernon Cancer Centre / University College London(弗农山癌症中心/伦敦大学学院)🌐UK

Professor of Clinical Oncology; Consultant in Clinical Oncology临床肿瘤学教授;临床肿瘤学顾问

57
h-index
3
Key Papers
4
Awards
3
Key Contributions

👥Biography 个人简介

Peter Hoskin is one of the UK's foremost authorities on brachytherapy and a world leader in clinical radiation oncology. He has conducted pivotal randomized trials comparing HDR and LDR brachytherapy techniques for prostate and gynecological cancers, contributed fundamentally to optimizing dose-fractionation in brachytherapy, and championed the integration of MRI guidance into gynecological brachytherapy planning. His textbooks and clinical guidelines have shaped brachytherapy practice internationally.

Share:

🧪Research Fields 研究领域

Brachytherapy近距离放射治疗
HDR Brachytherapy高剂量率近距离放射治疗
LDR Brachytherapy低剂量率近距离放射治疗
Prostate Brachytherapy前列腺近距离放射治疗
Cervical Cancer Brachytherapy宫颈癌近距离放射治疗
Palliative Radiotherapy姑息性放疗

🎓Key Contributions 主要贡献

HDR vs LDR Prostate Brachytherapy

Led prospective randomized trials and large observational studies establishing equivalency and in some settings superiority of HDR prostate brachytherapy boost compared to LDR seed implantation, influencing guidelines worldwide.

MRI-Guided Gynecological Brachytherapy

Advanced MRI-based image-guided adaptive brachytherapy for cervical cancer at Mount Vernon, contributing clinical outcomes data that supported the EMBRACE protocol and transformation of gynecological brachytherapy practice.

Radiobiological Modeling in Brachytherapy

Applied linear-quadratic modeling to brachytherapy dose optimization, establishing evidence-based protocols for HDR fraction sizes and total doses in prostate, cervix, and endometrial cancer.

Representative Works 代表性著作

[1]

HDR brachytherapy as monotherapy for localised prostate cancer: a hypofractionated two-implant approach in 351 consecutive patients

Radiotherapy and Oncology (2013)

Large single-center series establishing HDR monotherapy as an effective curative approach for localized prostate cancer.

[2]

Randomised trial of single and multifractionated radiotherapy in bone metastases

Clinical Oncology (1992)

Landmark trial demonstrating equivalent palliation from single-fraction radiotherapy versus multifraction schedules for bone metastases.

[3]

Brachytherapy (Oxford Clinical Oncology Series)

Oxford University Press (2021)

Definitive textbook on clinical brachytherapy, widely used in training radiation oncologists globally.

🏆Awards & Recognition 奖项与荣誉

🏆British Institute of Radiology Barclay Prize
🏆Royal College of Radiologists Roentgen Prize
🏆ESTRO Brachytherapy Award
🏆Fellowship of the Royal College of Radiologists (FRCR) by Election

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 彼得·霍斯金 的研究动态

Follow Peter Hoskin's research updates

留下邮箱,当我们发布与 Peter Hoskin(Mount Vernon Cancer Centre / University College London)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment